Human papillomavirus, human immunodeficiency virus and immunosuppression. Read more about Human papillomavirus, human immunodeficiency virus and immunosuppression.
Are young injection drug users ready and willing to participate in preventive HCV vaccine trials? Read more about Are young injection drug users ready and willing to participate in preventive HCV vaccine trials?
The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali. Read more about The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali.
Chapter 16: HPV vaccines in immunocompromised women and men. Read more about Chapter 16: HPV vaccines in immunocompromised women and men.
Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help. Read more about Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help.
Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection. Read more about Human immunodeficiency virus type 2 DNA vaccine provides partial protection from acute baboon infection.
Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates. Read more about Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.
Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries. Read more about Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries.
Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice. Read more about Distribution of adjuvant MF59 and antigen gD2 after intramuscular injection in mice.
Safety and immunogenicity of REMUNE in HIV-infected Thai subjects. Read more about Safety and immunogenicity of REMUNE in HIV-infected Thai subjects.
